Our venture capital fund focuses investments on early-stage life sciences companies looking to improve people’s outcomes with cancer.
Location: United States, Missouri, Saint Louis
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 10
| Date | Name | Website | Total Raised | Location |
| 30.09.2022 | AI Protein... | aiproteins... | $18.2M | United Sta... |
| 30.09.2022 | Microbial ... | microbialm... | $3.93M | United Sta... |
| 01.03.2022 | NextRNA Th... | nextrnatx.... | $46.8M | United Sta... |
| - | C4 Therape... | c4therapeu... | $243M | United Sta... |
| - | CareVet | carevethea... | $228M | United Sta... |
| - | Geneoscopy | geneoscopy... | $111.9M | United Sta... |
| - | Arch Oncol... | archoncolo... | $155M | United Sta... |
| - | MANA Thera... | manatherap... | $35M | - |
| - | Simple Ros... | simplerose... | - | United Sta... |
| - | Wugen | wugen.com | $172M | United Sta... |